Peptides are next frontline therapeutics led by GLP-1: Dr. Vandana Singh, Head - API Regulatory Sciences, Biocon Limited

Biocon is actively advancing in the peptide field, having already secured regulatory approvals for certain critical molecules, with a clear focus on GLP-1 analogs and other peptides